Typical timeline: Weeks 04 : Initial appetite suppression and modest weight loss, primarily fluid and glycogen Months 26 : Progressive weight loss with measurable reductions in waist circumference Months 612 : Continued but often slower weight loss, with maximum effect typically achieved by 1218 months Beyond 12 months : Weight maintenance phase
Patel et al., 1993)
GSH, GSSG, total glutathione, the GSH/GSSG ratio, and glutathione redox potential are related but not interchangeable
Injectable glutathione offers a direct intervention to counteract these depletive forces, potentially supporting cellular resilience in the face of modern oxidative challenges
GLP-1 medications can offer some extra support, thanks to their anti-inflammatory benefits
Lilly announces $3bn expansion to injectable drug manufacturing facility The pharma giant is expanding its site in Pleasant Prairie, Wisconsin after acquiring the facility from Nexus in April